- €1.63bn
- €2.68bn
- €4.44bn
- 65
- 65
- 95
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,441 | 3,145 | 3,507 | 4,160 | 4,442 |
Cost of Revenue | |||||
Gross Profit | 2,795 | 2,636 | 2,912 | 3,375 | 3,561 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,278 | 3,028 | 3,353 | 3,926 | 4,189 |
Operating Profit | 163 | 117 | 154 | 233 | 253 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 154 | 109 | 147 | 225 | 228 |
Provision for Income Taxes | |||||
Net Income After Taxes | 98.7 | 67.2 | 102 | 167 | 165 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 100 | 72.8 | 110 | 146 | 192 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 100 | 72.8 | 110 | 146 | 192 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.91 | 6.34 | 9.94 | 14.4 | 13.8 |
Dividends per Share |